AMBER STOKES: Open Payments
NPI 1548762701 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 10 payments from 5 companies in 2025. Trend: 2023 $137 · 2024 $291 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $125 |
| Dexcom, Inc. | 1 | $93 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Amgen Inc. | 1 | $14 |
Products named: Dexcom G6 Transmitter, Wegovy, Rybelsus, NUZYRA, QULIPTA, Ozempic, OTEZLA.
Industry payments across VA — which companies pay providers there.
